Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohort.
Saved in:
| Title: | Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohort. |
|---|---|
| Authors: | Kandane-Rathnayake R; Centre for Inflammatory Diseases, School of Clinical Sciences, Monash University, VIC, Clayton, Australia. rangi.kandane-rathnayake@monash.edu., Louthrenoo W; Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand., Lau CS; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam, Hong Kong., Hamijoyo L; Department of Internal Medicine, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia., Cho J; Rheumatology Division, Department of Medicine, National University Hospital, Singapore, Singapore., Lateef A; Department of Rheumatology, Division of Medicine, Woodlands Health, Singapore, Singapore., Luo SF; Department of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taipei, Taiwan, Republic of China., Wu YJ; Department of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Keelung, Taiwan, Republic of China., Navarra S; Section of Rheumatology, University of Santo Tomas Hospital, Manila, Philippines., Zamora L; Section of Rheumatology, University of Santo Tomas Hospital, Manila, Philippines., Li Z; Department of Rheumatology and Immunology, People's Hospital, Peking University Health Science Center, Beijing, China., Chen YH; Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan, Republic of China., Oon S; Department of Rheumatology, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia., Chan M; Department of Rheumatology, Allergy & Immunology, Tan Tock Seng Hospital, Tan Tock Seng, Singapore., Sockalingam S; Department of Medicine, Universiti Malaya Medical Centre, Kuala Lumpur, Malaysia., Hao Y; Department of Rheumatology, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia.; Rheumatology and Immunology department, Peking University First Hospital, Beijing, China., Zhang Z; Rheumatology and Immunology department, Peking University First Hospital, Beijing, China., Bae SC; Hanyang University Hospital for Rheumatic Diseases, Hanyang University Institute for Rheumatology Research and Hanyang Institute of Bioscience and Biotechnology, Seoul, South Korea., Kikuchi J; Department of Internal Medicine, Keio University, Tokyo, Japan., Takeuchi T; Department of Internal Medicine, Keio University, Tokyo, Japan.; Department of Rheumatology and Applied/Clinical Immunology, Saitama Medical University, Saitama, Japan., Katsumata Y; Department of Internal Medicine, Tokyo Women's Medical University, Tokyo, Japan., Basnayake B; Department of Nephrology, Teaching Hospital Kandy, Kandy, Sri Lanka., Goldblatt F; Department of Rheumatology, Flinders Medical Centre, Bedford Park, SA, Australia., O'Neill S; Rheumatology Department, Liverpool Hospital, Liverpool, NSW, Australia.; University of Sydney, Sydney, NSW, Australia., Pek Ling Ng K; Department of Rheumatology, North Shore Hospital, Health New Zealand Waitemata, Auckland, New Zealand., Tugnet N; Department of Rheumatology, Greenlane Clinical Centre, Health New Zealand Auckland, Te Whatu Ora, Auckland, New Zealand., Sapsford M; Department of Rheumatology, Middlemore Hospital, Health New Zealand Counties Manukau, Te Whatu Ora, Auckland, New Zealand., Poh YJ; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore, Singapore., Tee C; College of Medicine, University of the Philippines, Manila, Philippines., Tee M; College of Medicine, University of the Philippines, Manila, Philippines., Ohkubo N; The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan., Lefeber AO; Novartis Pharma, Basel, Switzerland., Shisha T; Novartis Pharma, Basel, Switzerland., Tanaka Y; The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan., Golder V; Centre for Inflammatory Diseases, School of Clinical Sciences, Monash University, VIC, Clayton, Australia.; Rheumatology Department, Monash Health, Clayton, VIC, Australia., Nikpour M; Department of Rheumatology, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia.; The University of Sydney School of Public Health, Sydney, NSW, Australia., Hoi A; Centre for Inflammatory Diseases, School of Clinical Sciences, Monash University, VIC, Clayton, Australia.; Rheumatology Department, Monash Health, Clayton, VIC, Australia., Gergely P; Novartis Pharma, Basel, Switzerland., Morand E; Centre for Inflammatory Diseases, School of Clinical Sciences, Monash University, VIC, Clayton, Australia.; Rheumatology Department, Monash Health, Clayton, VIC, Australia. |
| Source: | Arthritis research & therapy [Arthritis Res Ther] 2025 Jul 23; Vol. 27 (1), pp. 155. Date of Electronic Publication: 2025 Jul 23. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101154438 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-6362 (Electronic) Linking ISSN: 14786354 NLM ISO Abbreviation: Arthritis Res Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1478-6362 |
|---|---|
| DOI: | 10.1186/s13075-025-03622-8 |
